✦ LIBER ✦

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma

✍ Scribed by Bain, C; Merrouche, Y; Puisieux, I; Blay, J-Y; Negrier, S; Bonadona, V; Lasset, C; Lanier, F; Duc, A; Gebuhrer, L

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The hematologic toxicity of interleukin-

✍ Mark P. Macfarlane; James C. Yang; Anshu S. Guleria; Richard L White Jr.; Claudi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 744 KB

Subcutaneous low-dose recombinant interl

✍ Gaston, R; Oskam, R; Philip, T; Ravaud, A; Négrier, S; Cany, L; Merrouche, Y; Le 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 876 KB

Interleukin-2 dose, blood monocyte and C

✍ Gregers G. Hermann; Poul F. Geertsen; Hans von der Maase; Jesper Zeuthen 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 583 KB

Phase I/II study of thalidomide in combi

✍ Robert J. Amato; Margaret Morgan; Anish Rawat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Polyethylene glycol conjugated interleuk

✍ Ronald M. Bukowski; James Young; Gary Goodman; Frederick Meyers; Brian F. Issell 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 487 KB

Long-term complete response to very-low-

✍ Ken-ichi Harada; Hideaki Miyake; Toshifumi Kurahashi; Masato Fujisawa 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 333 KB